Sort
25,944 grants matching “neurodegeneration”
Genetic Drivers of Resilience to Alzheimer's Disease
$406,524Timothy J Hohman · Vanderbilt University Medical Center · R01 · FY2019 · AG
Identifying the sequences and factors that govern the fate of elongating RNAPII
$406,515Karen L Adelman · Harvard Medical School · R01 · FY2024 · GM
Mitochondrial Mechanisms in Optic Neuropathy
$406,450Gino A Cortopassi · University Of California At Davis · R01 · FY2007 · EY
CORE--NEUROPATHOLOGY CORE
$406,436Ronald Kim · University Of California-Irvine · P50 · FY2009 · AG
Role of TREM2 gain-of-function mutations in modulating microglial pathology in Alzheimer's disease
$406,400Ana Griciuc · Massachusetts General Hospital · R01 · FY2024 · AG
Role of TREM2 gain-of-function mutations in modulating microglial pathology in Alzheimer's disease
$406,400Ana Griciuc · Massachusetts General Hospital · R01 · FY2021 · AG
Role of TREM2 gain-of-function mutations in modulating microglial pathology in Alzheimer's disease
$406,400Ana Griciuc · Massachusetts General Hospital · R01 · FY2022 · AG
Role of TREM2 gain-of-function mutations in modulating microglial pathology in Alzheimer's disease
$406,400Ana Griciuc · Massachusetts General Hospital · R01 · FY2023 · AG
Inflammatory and hypoxia responses in neurodegeneration: A novel Drosophila model
$406,356Janis O'Donnell · University Of Alabama In Tuscaloosa · R15 · FY2012 · NS
Neuronal IL-1R1 Signaling in Mild Closed Head Injury
$406,308Adam D Bachstetter · University Of Kentucky · R01 · FY2024 · NS
Molecular and genetic studies of NMNAT2 in neuroprotection
$406,293Hui-Chen Lu · Trustees Of Indiana University · R01 · FY2018 · NS
Lysosomal Function of Progranulin and Neurodegeneration
$406,284Fenghua Hu · Cornell University · R01 · FY2017 · NS
Training in the Neurobiology of Aging
$406,272Carl W Cotman · University Of California-Irvine · T32 · FY2015 · AG
Development of an Oscillated Insertion tool to Eliminate Surgically Induced Neurodegeneration for Optical Neuroimaging of Cognitive Aging and Dementia
$406,263Kyle William Gheres · Actuated Medical, Inc. · R43 · FY2023 · AG
Optical Sensing of the Spread of Alpha-Synuclein Aggregates in Models of Parkinson's Disease and Related Dementias
$406,260Kevin J Webb · Purdue University · R21 · FY2024 · NS
Defining developmentally regulated retroelement-based mechanisms to better understand and treat their dysregulation in disease.
$406,250Andrew Joseph Modzelewski · University Of Pennsylvania · R35 · FY2025 · GM
Defining developmentally regulated retroelement-based mechanisms to better understand and treat their dysregulation in disease.
$406,250Andrew Joseph Modzelewski · University Of Pennsylvania · R35 · FY2024 · GM
Development of Immunological Reagents for the Identification of New World Monkey Biomarkers
$406,228Luis David Giavedoni · Trinity University · R24 · FY2024 · OD
Identification of modifiers of the neurodegenerative phenotype in nmd mice
$406,213Christian L. Lorson · University Of Missouri-Columbia · R21 · FY2019 · NS
Development Of P2Y Receptor Ligands
$406,169Kenneth Alan Jacobson · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2014 · DK
MITOCHONDRIA AND APOPTOSIS
$406,160Burnham Institute For Medical Research · R01 · FY2001 · GM
EXCITATION AND EXCITOTOXICITY IN TYPE I COCHLEAR AFFERENTS: SYNAPTIC STRUCTURE AND FUNCTION
$406,152Mark Allen Rutherford · Washington University · R01 · FY2017 · DC
EXCITATION AND EXCITOTOXICITY IN TYPE I COCHLEAR AFFERENTS: SYNAPTIC STRUCTURE AND FUNCTION
$406,152Mark Allen Rutherford · Washington University · R01 · FY2018 · DC
Project 3: Peripheral Immune Activation on the Road to Development of Alzheimer's Disease: Therapeutic Targets and Windows
$406,127Kathleen E. Rodgers · University Of Arizona · P01 · FY2023 · AG
Project 3: Peripheral Immune Activation on the Road to Development of Alzheimer's Disease: Therapeutic Targets and Windows
$406,127Kathleen E. Rodgers · University Of Arizona · P01 · FY2024 · AG